Capexil Profile
Key Indicators
- Company Age 66 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 37.90%
(FY 2023)
- Profit 84.88%
(FY 2023)
- Ebitda 72.96%
(FY 2023)
- Net Worth 10.70%
(FY 2023)
- Total Assets 6.12%
(FY 2023)
About Capexil
The Corporate was formerly known as Chemicals & Allied Products Export Promotion Council. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Kheruka, Rangaswami Veeramani, Ganesan Ashokan, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U36900WB1958NPL023786
- Company No.
023786
- Company Classification
Public Not For Profit Company
- Incorporation Date
28 Mar 1958
- Date of AGM
16 Oct 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Capexil offer?
Capexil offers a wide range of products and services, including Marketing Services & Consultants, Marketing Services, Project Feasibility Studies, Market Research Service.
Who are the key members and board of directors at Capexil?
Board Members(12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaidyalingam  | Director | 29-Dec-2020 | Current |
| Satish Malhotra | Director | 28-Mar-2016 | Current |
| Deependra Singh | Director | 17-Dec-2015 | Current |
| Ganesan Ashokan | Director | 18-Dec-1996 | Current |
| Pradeep Kheruka | Director | 13-Feb-2019 | Current |
| Rangaswami Veeramani | Director | 27-Jan-1990 | Current |
Financial Performance and Corporate Structure Insights of Capexil.
Capexil, for the financial year ended 2023, experienced significant growth in revenue, with a 37.9% increase. The company also saw a substantial improvement in profitability, with a 84.88% increase in profit. The company's net worth Soared by an impressive increase of 10.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Capexil?
Unlock access to Capexil's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
The Arasan Aluminium Industries Private LimitedActive 47 years 6 monthsGanesan Ashokan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Capexil?
Capexil has a workforce of 24 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Capexil, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Capexil's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
